Metformin high dosage and bleeding episode: A clinical case study

Area of Science:

• Endocrinology
• Pharmacology
• Internal Medicine

Background:

• Metformin is a first-line oral antihyperglycemic agent for type 2 diabetes mellitus.
• While generally safe, metformin can be associated with gastrointestinal and, rarely, other adverse effects.
• Optimizing glycemic control often involves dose titration, which may increase the risk of side effects.

Observation:

• A case report detailing a patient experiencing a bleeding episode.
• The bleeding event occurred subsequent to an upward titration of metformin dosage.
• The patient was undergoing metformin dose adjustment to achieve target glycemic control.

Findings:

• The case suggests a potential link between metformin dose escalation and the occurrence of a bleeding episode.
• This observation warrants consideration of bleeding risk during metformin therapy, particularly with dose increases.
• Further investigation may be needed to elucidate the mechanism and frequency of this adverse event.

Implications:

• Clinicians should be vigilant for bleeding complications in patients treated with metformin, especially during dose titration.
• This case underscores the importance of a comprehensive risk-benefit assessment for metformin therapy.
• Awareness of this potential side effect can aid in timely diagnosis and management of metformin-associated bleeding.